Hospital to check cholesterol
Nanticoke Memorial Hospital, Seaford, will offer cholesterol screenings on Feb. 14, 19 and 22, from 7:30 to 10 a.m. in the Community Room of the hospital. Participants will have the opportunity to select from two types of blood tests.
One option is a total cholesterol test, which is a non-fasting blood test that will read the total cholesterol level. The cost is $5.
The second option is a lipid profile test, which requires a 12-hour fasting and reads the HDL and LDL blood levels. Cost for the lipid profile is $15.
In addition to the cholesterol screening, free blood pressure checks will be offered. Several display tables will be available this year, providing information on nutrition, cardiac rehabilitation and stop smoking program.
Employees representing laboratory services, Corporate Education and Cardiac Rehabilitation will assist with the screenings. Results from the cholesterol screening will be mailed approximately two weeks after the test is performed.
For additional information, call 629-6611 extension. 2404.
Brady ends CVS investigation
Attorney General M. Jane Brady announced Jan. 9 that Delaware and 18 other jurisdictions have settled a multi-state investigation into alleged unfair deceptive billing practices of CVS Pharmacies Inc.
The settlement resolves allegations that CVS initially charged consumers the full amount for prescriptions that were not completely filled due to insufficient inventory and then retained the excess payment if the consumer did not return to pick up the balance of the prescription at a later date.
This is the second settlement involving CVS’s billing practices. During April 2001, following an investigation by the Department of Justice and the National Association of Medicaid Fraud Units, CVS agreed to settle claims that it billed federal and state health care programs for quantities of medication that exceeded the amounts actually given to consumers.
“Many of the consumers affected by these illegal practices could little afford to be shortchanged. This settlement ensures that consumers will be getting what they pay for,” said Brady.
Under the settlement, CVS is required to develop and implement pharmacy billing policies designed to prevent consumers from being billed for medication until the entire amount prescribed has been dispensed and to ensure future compliance with the state’s consumer protection laws.
CVS has also agreed to pay Delaware and the other jurisdictions a total of $1.1 million in penalties and costs.
Delaware will receive $38,219.12 from the settlement proceeds. Of that amount, the settlement reserves $10,719.12 to be made available to benefit low-income, disabled or elderly consumers of prescription medications.